Lazard Capital Upgrades Alexion Pharmaceuticals (ALXN) to Buy

February 20, 2013 7:34 AM EST
Get Alerts ALXN Hot Sheet
Price: $134.35 -1.12%

Rating Summary:
    20 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 23 | Down: 34 | New: 34
Trade ALXN Now!
Join SI Premium – FREE
Lazard Capital upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from Neutral to Buy.

For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.

Shares of Alexion Pharmaceuticals closed at $83.39 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment